Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avidity Biosciences Inc (RNA)
:RNA
RESEARCH TOOLSreports
Holding RNA?
Track your performance easily
Avidity Biosciences (RNA) Ownership Overview
1.57% Insiders
33.65% Mutual Funds
0.15% Other Institutional Investors
15.16% ETFs
49.48% Public Companies and Individual Investors
The ownership structure of Avidity Biosciences (RNA) stock is a mix of institutional, retail, and individual investors. Approximately 48.95% of the company’s stock is owned by Institutional Investors, 1.57% is owned by Insiders, and 49.48% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 09, 2024 | Thompson Tamar Director | xxxxxxxxxxxxx | $1349100 |
| Apr 03, 2024 | Sarah Boyce President & Ceo,director | xxxxxxxxxxxxx | $734720 |
| Apr 03, 2024 | Arthur Levin Director | xxxxxxxxxxxxx | $542200 |
| Mar 21, 2024 | Arthur Levin Director | xxxxxxxxxxxxx | $119800 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $31147613 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $40048387 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $289377739 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,556,375 | Institution | 7.17% | 238,466,171 | |
| 7,617,181 | Institution | 6.38% | 212,290,834 | |
| 6,300,408 | Institution | 5.28% | 175,592,371 | |
| 5,680,625 | Institution | 4.76% | 158,319,019 | |
| 5,113,756 | Institution | 4.29% | 142,520,380 | |
| 4,479,036 | Institution | 3.75% | 124,830,733 | |
| 2,555,130 | Institution | 2.14% | 71,211,473 | |
| 2,468,317 | Institution | 2.07% | 68,791,995 | |
| 2,353,589 | Institution | 1.97% | 65,594,525 | |
| 2,200,622 | Institution | 1.84% | 61,331,335 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,617,181 | Institution | 6.38% | 212,290,834 | |
| 5,680,625 | Institution | 4.76% | 158,319,019 | |
| 4,479,036 | Institution | 3.75% | 124,830,733 | |
| 2,555,130 | Institution | 2.14% | 71,211,473 | |
| 2,468,317 | Institution | 2.07% | 68,791,995 | |
| 2,353,589 | Institution | 1.97% | 65,594,525 | |
| 1,560,106 | Institution | 1.31% | 43,480,154 | |
| 1,179,749 | Institution | 0.99% | 32,879,605 | |
| 1,087,263 | Institution | 0.91% | 30,302,020 | |
| 1,011,661 | Institution | 0.85% | 28,194,992 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,498,149 | Institution | 2.93% | 150,525,351 | |
| 2,957,952 | Institution | 2.48% | 82,438,122 | |
| 1,973,837 | Institution | 1.65% | 53,392,291 | |
| 1,753,460 | Institution | 1.47% | 75,451,384 | |
| 1,401,995 | Institution | 1.18% | 60,327,845 | |
| 1,016,407 | Institution | 0.85% | 28,327,263 | |
| 947,946 | Institution | 0.79% | 40,790,116 | |
| 690,967 | Institution | 0.58% | 19,257,250 | |
| 578,220 | Institution | 0.48% | 15,640,851 | |
| 508,120 | Institution | 0.43% | 21,864,404 |
FAQ
Who Owns Avidity Biosciences Inc (RNA)?
According to the latest TipRanks data, approximately 0.15% of the company's stock is held by institutional investors, 1.57% is held by insiders, and 49.48% is held by retail investors.
What percentage of Avidity Biosciences Inc (RNA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.15% of Avidity Biosciences Inc (RNA) stock is held by institutional investors.
What percentage of Avidity Biosciences Inc (RNA) stock is held by retail investors?
According to the latest TipRanks data, approximately 49.48% of Avidity Biosciences Inc (RNA) stock is held by retail investors.
Who owns the most shares of Avidity Biosciences Inc (RNA)?
Vanguard owns the most shares of Avidity Biosciences Inc (RNA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.